BCM
VIVO

Brown Capital Management’s Meridian Bioscience Inc VIVO Stock Holding History

Brown Capital Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-42,117
Closed -$411K – 125
2019
Q4 		$411K Sell
42,117
-2,430,112
-98% -$22.8M ﹤0.01% 107
2019
Q3 		$23.5M Sell
2,472,229
-1,127,563
-31% -$11.9M 0.23% 42
2019
Q2 		$42.8M Sell
3,599,792
-25,218
-0.7% -$304K 0.41% 36
2019
Q1 		$63.8M Sell
3,625,010
-32,655
-0.9% -$543K 0.65% 34
2018
Q4 		$63.5M Sell
3,657,665
-6,254
-0.2% -$107K 0.76% 33
2018
Q3 		$54.6M Hold
3,663,919
– – 0.5% 33
2018
Q2 		$58.3M Sell
3,663,919
-344,320
-9% -$5.14M 0.6% 32
2018
Q1 		$56.9M Sell
4,008,239
-656,904
-14% -$9.72M 0.65% 32
2017
Q4 		$65.3M Sell
4,665,143
-828,323
-15% -$12.1M 0.79% 29
2017
Q3 		$78.6M Sell
5,493,466
-156,991
-3% -$2.24M 0.96% 29
2017
Q2 		$89M Sell
5,650,457
-32,638
-0.6% -$470K 1.09% 29
2017
Q1 		$78.4M Sell
5,683,095
-8,536
-0.1% -$119K 1.05% 29
2016
Q4 		$101M Sell
5,691,631
-28,307
-0.5% -$497K 1.47% 25
2016
Q3 		$110M Sell
5,719,938
-4,838
-0.1% -$94.7K 1.62% 24
2016
Q2 		$112M Buy
5,724,776
+14,900
+0.3% +$292K 1.76% 23
2016
Q1 		$118M Buy
5,709,876
+202,400
+4% +$3.99M 1.95% 22
2015
Q4 		$113M Buy
5,507,476
+47,347
+0.9% +$908K 1.77% 24
2015
Q3 		$93.4M Buy
5,460,129
+1,021,158
+23% +$18.7M 1.6% 24
2015
Q2 		$82.7M Sell
4,438,971
-20,575
-0.5% -$382K 1.36% 25
2015
Q1 		$85.1M Hold
4,459,546
– – 1.4% 25
2014
Q4 		$73.4M Sell
4,459,546
-69,440
-2% -$1.19M 1.27% 25
2014
Q3 		$80.1M Sell
4,528,986
-246,814
-5% -$4.85M 1.42% 25
2014
Q2 		$98.6M Buy
4,775,800
+135,886
+3% +$2.79M 1.64% 25
2014
Q1 		$101M Sell
4,639,914
-16,734
-0.4% -$384K 1.67% 26
2013
Q4 		$124M Buy
4,656,648
+375,534
+9% +$9.23M 2.02% 24
2013
Q3 		$101M Buy
4,281,114
+19,663
+0.5% +$459K 1.78% 27
2013
Q2 		$91.6M Buy
+4,261,451
New +$91.9M 1.96% 23

Other funds holding VIVO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Brown Capital Management's VIVO Position: Q1 2020 in Review

Brown Capital Management sold out of Meridian Bioscience Inc (VIVO) in Q1 2020, closing a stake of 42,117 shares — an estimated $411K sold.

Brown Capital Management first reported a position in VIVO in Q2 2013 and held it in 27 quarters. The position peaked at $124M in Q4 2013. 168 funds tracked by Wall St. Rank hold VIVO as of Q1 2020.

  • Brown Capital Management reported no remaining Meridian Bioscience Inc position as of Q1 2020 after selling out during the quarter.
  • Brown Capital Management sold 42,117 Meridian Bioscience Inc shares in Q1 2020, an estimated $411K.
  • Brown Capital Management first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 27 quarters.
  • Brown Capital Management's Meridian Bioscience Inc position peaked at $124M in Q4 2013.
  • 168 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2020.

Based on Brown Capital Management's 13F filing for Q1 2020, filed 8 May 2020.